The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)
Lists
Only you see this
Abstract
Patients who have moderately severe strokes and longer OTT demonstrate better treatment effects with MLC601. These factors can guide patient selection in future trials.
BibTeX
@article{venketasubramanian2015value,
author = {Narayanaswamy Venketasubramanian and Chun Fan Lee and Ka Sing Wong and Christopher Chen},
title = {{The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)}},
journal = {Journal of Evidence-Based Medicine},
year = {2015},
doi = {10.1111/jebm.12170},
}Loading related content...